Daniel Hoffmann Selected Research

Daniel Hoffmann Research Topics

Disease

14	Infections 01/2022 - 06/2010
10	Neoplasms (Cancer) 11/2022 - 01/2013
3	Virus Diseases (Viral Diseases) 10/2023 - 01/2015
3	COVID-19 01/2021 - 01/2020
2	Parkinson Disease (Parkinson's Disease) 04/2024 - 10/2013
2	Merkel Cell Carcinoma 01/2022 - 01/2020
2	Hypertrophy 01/2020 - 01/2019
2	Wounds and Injuries (Trauma) 03/2019 - 06/2009
1	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2024
1	Noncommunicable Diseases 09/2022
1	Coinfection 09/2022
1	Carcinogenesis 01/2022
1	Abscess 11/2021
1	Melanoma (Melanoma, Malignant) 06/2021
1	Testicular Neoplasms (Testicular Cancer) 06/2021
1	Autolysis 08/2020
1	Glioma (Gliomas) 04/2020
1	Skin Neoplasms (Skin Cancer) 01/2020
1	Vesicular Stomatitis 01/2020
1	Persistent Infection 01/2019
1	Osteitis 01/2019
1	Acquired Immunodeficiency Syndrome (AIDS) 12/2018
1	Cryoglobulinemia 01/2018
1	Osteochondroma (Osteocartilaginous Exostosis) 01/2018
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2018
1	Hepatitis D 01/2018
1	Myocardial Infarction 10/2015
1	Breast Neoplasms (Breast Cancer) 01/2015
1	Superinfection 01/2015
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2015
1	Pseudomonas Infections 01/2015
1	Alzheimer Disease (Alzheimer's Disease) 10/2013
1	Chronic Hepatitis B 02/2013
1	Morbid Obesity 01/2013
1	Neoplasm Metastasis (Metastasis) 01/2013
1	Prader-Willi Syndrome (Syndrome, Prader-Willi) 09/2012

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 04/2024 - 02/2003
4	EpitopesIBA 01/2022 - 07/2015
3	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2019
3	Antiviral Agents (Antivirals)IBA 01/2020 - 02/2013
2	Interferon Type IIBA 10/2023 - 01/2015
2	Peptide Hydrolases (Proteases)FDA Link 11/2022 - 06/2009
2	Biomarkers (Surrogate Marker)IBA 09/2022 - 01/2015
2	VaccinesIBA 01/2022 - 01/2018
2	DNA (Deoxyribonucleic Acid)IBA 11/2021 - 01/2019
2	Peptides (Polypeptides)IBA 01/2019 - 01/2018
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2019 - 07/2015
2	NucleosidesIBA 02/2013 - 06/2010
1	Basic Amino Acids (Basic Amino Acid)IBA 04/2024
1	InterferonsIBA 10/2023
1	Aspartate Ammonia-LyaseIBA 11/2022
1	Threonine (L-Threonine)FDA Link 11/2022
1	Polycomb Repressive Complex 2IBA 01/2022
1	AntibodiesIBA 01/2022
1	Hepatitis B e AntigensIBA 01/2022
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 11/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 06/2021
1	AntigensIBA 06/2021
1	Butyrates (Butyrate)IBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	PolymersIBA 08/2020
1	SaltsIBA 08/2020
1	TrypsinIBA 08/2020
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2020
1	Wnt ProteinsIBA 01/2020
1	chenodeoxycholate sulfate conjugate (CDCS)IBA 01/2020
1	alpha E integrinsIBA 01/2020
1	Differentiation AntigensIBA 01/2020
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	Pancreatic Elastase (Elastase)IBA 03/2019
1	ThermolysinIBA 03/2019
1	Metalloproteases (Metalloproteinases)IBA 03/2019
1	Glutathione Transferase (Glutathione S-Transferase)IBA 03/2019
1	Virulence Factors (Pathogenicity Factors)IBA 03/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2019
1	TCVSIBA 01/2019
1	purmorphamineIBA 01/2019
1	Broadly Neutralizing AntibodiesIBA 12/2018
1	Immunoglobulin M (IgM)IBA 01/2018
1	HLA-B Antigens (HLA-B)IBA 01/2018
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2018
1	CateninsIBA 01/2018
1	Adenosine Triphosphate (ATP)IBA 08/2017
1	ArginaseIBA 08/2017
1	EnzymesIBA 08/2017
1	LigandsIBA 08/2017
1	fibroblast activation protein alphaIBA 10/2015
1	Interferon-alpha (Interferon Alfa)IBA 01/2015
1	Phosphotransferases (Kinase)IBA 01/2014
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2014
1	NucleotidesIBA 02/2013
1	Cetuximab (Erbitux)FDA Link 01/2013
1	Immunoglobulin G (IgG)IBA 01/2013
1	Hyaluronic Acid (Hyaluronan)IBA 01/2013
1	Immunoglobulins (Immunoglobulin)IBA 06/2011

Therapy/Procedure

9	Therapeutics 04/2024 - 01/2012
1	Radiotherapy 11/2021
1	Drug Therapy (Chemotherapy) 04/2020
1	Immunotherapy 01/2020
1	Bariatric Surgery 01/2013